11 August 2026
11 August 2026
Seven diseases have been stripped from the recommendations, with changes to the MMR vaccine also advised.
The MHRA is the first European regulator to give Foundayo a regulatory blessing, with the drug still under review by the EU.
This will establish BMS’ in-house manufacturing presence in Texas, adding to its ongoing outlicensing and research partnerships in the state.
As part of the deal, Actio Biosciences will spin out a new company focused on genetic rare neurological diseases.
The partnership will focus on developing combination therapies for patients with RAS-addicted cancers.
Experts predict that DHTs such as wearables and health apps will play a burgeoning role in obesity research and care, though barriers to equitable access remain.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
